Status:
COMPLETED
COVID-19 and Chilblains
Lead Sponsor:
Rennes University Hospital
Conditions:
Chilblains
COVID-19
Eligibility:
All Genders
Phase:
NA
Brief Summary
Chilblains (inflammatory lesion of the feet or hands) have been reported with an unusual frequency during the confinement period, most commonly in children, teenagers and young adults. The aim of the ...
Eligibility Criteria
Inclusion
- "case family"
- at least one of the members with chilblains
- diagnosis of chilblains (anamnesis and pictures) written informed consent
- "comparator family"
- none of the members with chilblains
- one member matched on age (+/- 1 year) to a patient with chilblains
- written informed consent
Exclusion
- \- Subject legally protected (under judicial protection, guardianship), persons deprived of liberty
Key Trial Info
Start Date :
July 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 19 2020
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT04455308
Start Date
July 21 2020
End Date
October 19 2020
Last Update
January 8 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France, 49933
2
CHRU Brest
Brest, France, 29609
3
CHU Nantes
Nantes, France, 44093
4
CHU Rennes
Rennes, France, 35033